Pommier Y - Search Results

1

The exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacology.

Abaan OD, Polley EC, Davis SR, Zhu YJ, Bilke S, Walker RL, Pineda M, Gindin Y, Jiang Y, Reinhold WC, Holbeck SL, Simon RM, Doroshow JH, Pommier Y, Meltzer PS. Abaan OD, et al. Among authors: pommier y. Cancer Res. 2013 Jul 15;73(14):4372-82. doi: 10.1158/0008-5472.CAN-12-3342. Epub 2013 Jul 15. Cancer Res. 2013. PMID: 23856246 Free PMC article.

2

Topoisomerase I alteration in a camptothecin-resistant cell line derived from Chinese hamster DC3F cells in culture.

Tanizawa A, Pommier Y. Tanizawa A, et al. Among authors: pommier y. Cancer Res. 1992 Apr 1;52(7):1848-54. Cancer Res. 1992. PMID: 1312902

3

Differential effects of amsacrine and epipodophyllotoxins on topoisomerase II cleavage in the human c-myc protooncogene.

Pommier Y, Orr A, Kohn KW, Riou JF. Pommier Y, et al. Cancer Res. 1992 Jun 1;52(11):3125-30. Cancer Res. 1992. PMID: 1317259

4

Differential induction of secondary DNA fragmentation by topoisomerase II inhibitors in human tumor cell lines with amplified c-myc expression.

Bertrand R, Sarang M, Jenkin J, Kerrigan D, Pommier Y. Bertrand R, et al. Among authors: pommier y. Cancer Res. 1991 Dec 1;51(23 Pt 1):6280-5. Cancer Res. 1991. PMID: 1933888

5

DNA strand breaks produced by etoposide (VP-16,213) in sensitive and resistant human breast tumor cells: implications for the mechanism of action.

Sinha BK, Haim N, Dusre L, Kerrigan D, Pommier Y. Sinha BK, et al. Among authors: pommier y. Cancer Res. 1988 Sep 15;48(18):5096-100. Cancer Res. 1988. PMID: 2842045

6

Topoisomerase I-related parameters and camptothecin activity in the colon carcinoma cell lines from the National Cancer Institute anticancer screen.

Goldwasser F, Bae I, Valenti M, Torres K, Pommier Y. Goldwasser F, et al. Among authors: pommier y. Cancer Res. 1995 May 15;55(10):2116-21. Cancer Res. 1995. PMID: 7743511

7

Unscheduled activation of cyclin B1/Cdc2 kinase in human promyelocytic leukemia cell line HL60 cells undergoing apoptosis induced by DNA damage.

Shimizu T, O'Connor PM, Kohn KW, Pommier Y. Shimizu T, et al. Among authors: pommier y. Cancer Res. 1995 Jan 15;55(2):228-31. Cancer Res. 1995. PMID: 7812949

8

Mutation at the catalytic site of topoisomerase I in CEM/C2, a human leukemia cell line resistant to camptothecin.

Fujimori A, Harker WG, Kohlhagen G, Hoki Y, Pommier Y. Fujimori A, et al. Among authors: pommier y. Cancer Res. 1995 Mar 15;55(6):1339-46. Cancer Res. 1995. PMID: 7882333

9

Hydroxyrubicin, a deaminated derivative of doxorubicin, inhibits mammalian DNA topoisomerase II and partially circumvents multidrug resistance.

Solary E, Ling YH, Perez-Soler R, Priebe W, Pommier Y. Solary E, et al. Among authors: pommier y. Int J Cancer. 1994 Jul 1;58(1):85-94. doi: 10.1002/ijc.2910580115. Int J Cancer. 1994. PMID: 8014019

10

Topoisomerase II inhibition and cytotoxicity of the anthrapyrazoles DuP 937 and DuP 941 (Losoxantrone) in the National Cancer Institute preclinical antitumor drug discovery screen.

Leteurtre F, Kohlhagen G, Paull KD, Pommier Y. Leteurtre F, et al. Among authors: pommier y. J Natl Cancer Inst. 1994 Aug 17;86(16):1239-44. doi: 10.1093/jnci/86.16.1239. J Natl Cancer Inst. 1994. PMID: 8040892

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

843 results

Search Page

Filters